经导管肺动脉瓣植入术（PPVI）应用Meril's Myval瓣膜治疗右室流出道术后功能障碍的疗效及安全性研究。纳入127例患者，124例（97.6%）成功完成PPVI，术后右室压力及梯度显著降低（p0.001），中位随访1.6年无感染、瓣膜断裂或死亡，仅1例出现轻微反流。该术式对既往 ...

Sanjeev Bhatt, Senior Vice President – Strategy, Meril said: “This investment by ADIA reinforces confidence in Meril’s long term vision and global ambitions. A wholly owned subsidiary of the Abu Dhabi ...

https://www.thehindubusinessline.com/news/national/meril-pushes-ahead-on-growth-plans-in-the-country-and-abroad/article67447410.ece Copy Indian medical devices maker ...

Meril Life Sciences' LANDMARK trial, highlighting the safety and effectiveness of the Myval Transcatheter Heart Valve Series, stands out as a key late-breaking trial at EuroPCR 2024. The trial ...

On Monday, U.S. heart valve manufacturer Edwards Lifesciences Corporation (NYSE:EW) faced an EU antitrust complaint from Indian competitor Meril, alleging anti-competitive behavior, particularly ...

New Delhi: Advancing its facilities Meril, an India-based medical device company, announced the launch of its indigenously developed advanced surgical robotic technology, MISSO, which will provide ...

Meril Life Sciences, a leading global med-tech company specializing in cardiovascular and structural heart solutions, marked a significant milestone with the launch of its Myval Octapro Transcatheter ...

Panel to decide if Sun Pharma’s anti-cancer drug, Meril’s biodegradable stent have therapeutic advantage Mumbai-based Sun Pharmaceuticals is seeking an exemption for its anti-cancer gemcitabine ...